- Home
- TTI vs COLL Comparison
TTI vs COLL Comparison
Compare TTI & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TTI | COLL |
|---|---|---|
| Founded | 1981 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1990 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TTI | COLL |
|---|---|---|
| Price | $11.71 | $45.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.25 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 2.1M | 493.9K |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7085.43 | N/A |
| EPS | 0.92 | ★ 1.63 |
| Revenue | $618,755,000.00 | ★ $757,067,000.00 |
| Revenue This Year | $5.52 | $26.17 |
| Revenue Next Year | $4.44 | $3.65 |
| P/E Ratio | ★ $12.68 | $28.85 |
| Revenue Growth | 0.17 | ★ 26.34 |
| 52 Week Low | $2.03 | $23.23 |
| 52 Week High | $11.71 | $50.79 |
Technical Indicators
Market Signals| Indicator | TTI | COLL |
|---|---|---|
| Relative Strength Index (RSI) | 80.27 | 44.54 |
| Support Level | $9.47 | $45.00 |
| Resistance Level | $10.24 | $49.17 |
| Average True Range (ATR) | 0.49 | 1.97 |
| MACD | 0.16 | -0.31 |
| Stochastic Oscillator | 89.81 | 16.81 |
Price Performance
Historical ComparisonAbout TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.